摘要
目的:了解泌尿生殖道支原体感染及其对抗生素的敏感情况,为临床合理用药提供参考依据。方法:对315例泌尿生殖道感染患者进行支原体培养、鉴定、计数及9种抗生素药敏试验检测。结果:315例疑似非淋菌性尿道炎(NGU)患者中支原体阳性125例,感染率为39.67%;其中解脲脲原体(Uu)感染为101例占32.06%;人型支原体(Mh)感染为10例占3.17%;解脲脲原体合并人型支原体(Uu+Mh)混合感染为14例占4.44%。支原体药物敏感结果显示:强力霉素、原始霉素、交沙霉素、四环素对支原体的药物敏感率分别为99.20%,97.60%,96.80%,94.40%。结论:泌尿生殖道支原体培养及其药敏检测,对于指导临床用药治疗具有重要意义,目前强力霉素、原始霉素、交沙霉素、四环素可作为临床支原体感染首选药物。
Objective： To investigate the infection of urogenitial tract mycoplasma and its susceptibility to antibiotics. Methotis： Mycoplasmas from 315 patients with urethritis infection were cultureed, identified, and counted. And then the drug susceptibility tests of nine antibiotics were carried out on positive samples. Results： Among the 315 patients suspected of non-gonococcus urethritis （NGU）, 125 cases were mycoplasma-positive, accounting for 39.67% of the total. 101 samples were the infection of Ureaplasma urealyticum （Uu）, accounting for 32.06% of the total. 10 samples were the infection of Mycoplasma hominis （Mh）, accounting for 3.17% of the total. 14 samples were the combinated infection of Uu and Mh, accounting for 4.44% of the total. The results of drug sensitivity tests showed that the sensitivity rates of urethritis mycoplasma to doxycycline, pristinamycine, josamycin, and tetracyclines were 99.20%, 97.60%, 96.80% and 94.40%, respectively. Conclusion： The culture of mycoplasma and the test of susceptibility to antibiotics were important to clinical treatment. Now, doxycycline, pristinamycine, josamycin and tetracyclines can be employed as the firstchoice drugs to the treatment of the infection of mycoplasma.
出处
《中国药物应用与监测》
CAS
2008年第6期4-6,共3页
Chinese Journal of Drug Application and Monitoring
关键词
解脲脲原体
人型支原体
药物敏感试验
Ureaplasma urealyticum
Mycoplasma hominis
Drug sensitivity test
